Soleno Therapeutics (SLNO) Other Working Capital Changes: 2013-2019
Historic Other Working Capital Changes for Soleno Therapeutics (SLNO) over the last 6 years, with Dec 2019 value amounting to -$42,000.
- Soleno Therapeutics' Other Working Capital Changes fell 120.79% to -$42,000 in Q4 2019 from the same period last year, while for Dec 2019 it was -$360,000, marking a year-over-year decrease of 700.00%. This contributed to the annual value of $750,000 for FY2024, which is 10.39% down from last year.
- Soleno Therapeutics' Other Working Capital Changes amounted to -$42,000 in Q4 2019, which was up 46.84% from -$79,000 recorded in Q3 2019.
- Soleno Therapeutics' 5-year Other Working Capital Changes high stood at $202,000 for Q4 2018, and its period low was -$175,000 during Q2 2018.
- Moreover, its 3-year median value for Other Working Capital Changes was -$44,500 (2018), whereas its average is -$16,917.
- Per our database at Business Quant, Soleno Therapeutics' Other Working Capital Changes slumped by 8,700.00% in 2015 and then surged by 928.57% in 2016.
- Quarterly analysis of 5 years shows Soleno Therapeutics' Other Working Capital Changes stood at -$57,630 in 2015, then slumped by 142.15% to -$139,552 in 2016, then skyrocketed by 241.88% to $198,000 in 2017, then climbed by 2.02% to $202,000 in 2018, then crashed by 120.79% to -$42,000 in 2019.
- Its last three reported values are -$42,000 in Q4 2019, -$79,000 for Q3 2019, and -$122,000 during Q2 2019.